Subcutaneous daratumumab with lenalidomide significantly increased MRD-negative conversion rates compared to lenalidomide ...
Post-CAR T infection prophylaxis should follow European Hematology Association/European Society for Blood and Marrow ...
Shane Dormady, MD, discusses the unique emotional care needs of young adults with cancer, emphasizing hope and holistic support for better outcomes. Cancer care for younger adults emphasizes emotional ...
The FDA approved Guardant 360 CDx for identifying ESR1 mutations in advanced breast cancer patients eligible for imlunestrant ...
David Chism, MD: For pairing it with the immunotherapy, I would prefer just 1 chemotherapy rather than ...
Cancer care for younger adults emphasizes emotional well-being and multidisciplinary support, transforming treatment ...
In this episode of the Treating Together podcast, Edward S. Kim, MD, MBA, and Neel Shah, MD, discuss the rapid advancements in lung cancer therapy, the challenges community physicians face in staying ...
In an interview with Targeted Oncology, Shane Dormady, MD, medical director of El Camino Health Cancer Center, highlights the unique challenges and differences in the priorities o ...
Explore the latest advancements in muscle-invasive bladder cancer treatment, including immunotherapy and novel therapies ...
The challenge of managing relapsed or refractory B-cell malignancies continues to thwart the efforts of oncologists and ...
The FDA has approved a new subcutaneous (SC) formulation of pembrolizumab (Keytruda Qlex), co-formulated with ...
The IMFORTE trial represents a breakthrough for patients with ES-SCLC who complete initial treatment without disease progression, offering new hope through maintenance therapy wit ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback